Aquilo Capital Management, LLC / RGNX
Aquilo Capital Management, LLC’s Regenxbio Inc Position
Does Aquilo Capital Management, LLC own Regenxbio Inc (RGNX)? Not currently — the last reported position was 271.3K shares worth $2M in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.
Position Value
$2M
Q1 2025
Shares
271.3K
% of Portfolio
+3.48%
Quarters Held
22
position exited
Position History RGNX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 271.3K | $2M | +3.48% |
| Q4 2024 | 346.3K | $3M | +4.04% |
| Q3 2024 | 930.7K | $10M | +7.40% |
| Q2 2024 | 906.2K | $11M | +10.22% |
| Q1 2024 | 906.2K | $19M | +14.31% |
| Q4 2023 | 802.4K | $14M | +8.98% |
| Q3 2023 | 847.4K | $14M | +12.64% |
| Q2 2023 | 870.1K | $17M | +9.64% |
| Q1 2023 | 831.0K | $16M | +6.51% |
| Q4 2022 | 897.7K | $20M | +7.65% |
| Q3 2022 | 967.7K | $26M | +9.22% |
| Q2 2022 | 1.17M | $29M | +9.84% |
| Q1 2022 | 1.12M | $37M | +5.46% |
| Q4 2021 | 1.01M | $33M | +3.76% |
| Q3 2021 | 839.1K | $35M | +6.39% |
| Q2 2021 | 595.4K | $23M | +6.01% |
| Q1 2021 | 559.4K | $19M | +3.45% |
| Q4 2020 | 503.4K | $23M | +4.75% |
| Q3 2020 | 510.8K | $14M | +1.49% |
| Q2 2020 | 553.5K | $20M | +4.11% |
| Q1 2020 | 273.2K | $9M | +3.45% |
| Q4 2019 | 268.8K | $11M | +4.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of RGNX.